Short-term feasibility studies of the 8 lead compounds in reducing Aβ neuropathology in Tg2576 mouse model of AD.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
Tg2576 mice were treated with 2 mg/kg/day of the candidate compound delivered through their drinking water for 4 weeks, Body weight, brain neuropathology including oligomeric Aβ as well as total brain Aβ were compared to vehicle-treated control Tg2576 mice (n = 5 per group, *p<0.05).
创建时间：
2014-03-26
